Healthcare provider profile · identity verified

Humera Malik, MD

Internal Medicine · SAGINAW, MI · NPI 1861704660

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	406	112
Atorvastatin Calcium	Atorvastatin Calcium	393	109
Levothyroxine Sodium	Levothyroxine Sodium	371	84
Losartan Potassium	Losartan Potassium	277	68
Gabapentin	Gabapentin	232	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	231	41
Lisinopril	Lisinopril	231	64
Omeprazole	Omeprazole	199	56
Simvastatin	Simvastatin	177	46
Metformin Hcl	Metformin Hcl	162	48
Metoprolol Tartrate	Metoprolol Tartrate	155	41
Hydrochlorothiazide	Hydrochlorothiazide	141	41
Alendronate Sodium	Alendronate Sodium	138	35
Alprazolam	Alprazolam	135	33
Pravastatin Sodium	Pravastatin Sodium	124	37
Pantoprazole Sodium	Pantoprazole Sodium	117	43
Atenolol	Atenolol	99	24
Potassium Chloride	Potassium Chloride	99	33
Tramadol Hcl	Tramadol Hcl	97	22
Albuterol Sulfate Hfa	Albuterol Sulfate	91	33
Jardiance	Empagliflozin	90	22
Zolpidem Tartrate	Zolpidem Tartrate	89	12
Furosemide	Furosemide	88	33
Metoprolol Succinate	Metoprolol Succinate	86	22
Tamsulosin Hcl	Tamsulosin Hcl	83	21
Duloxetine Hcl	Duloxetine Hcl	81	19
Fluticasone Propionate	Fluticasone Propionate	79	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	76	21
Eliquis	Apixaban	75	20
Allopurinol	Allopurinol	69	19
Meloxicam	Meloxicam	67	17
Carvedilol	Carvedilol	64	15
Montelukast Sodium	Montelukast Sodium	64	18
Ozempic	Semaglutide	64	15
Donepezil Hcl	Donepezil Hcl	62	12
Prednisone	Prednisone	62	14
Fluoxetine Hcl	Fluoxetine Hcl	61	17
Ibuprofen	Ibuprofen	59	suppressed
Lorazepam	Lorazepam	59	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	57	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	15
Glipizide	Glipizide	52	16
Famotidine	Famotidine	50	13
Synthroid	Levothyroxine Sodium	50	14
Tizanidine Hcl	Tizanidine Hcl	50	20
Bupropion Xl	Bupropion Hcl	49	13
Clonazepam	Clonazepam	48	suppressed
Ventolin Hfa	Albuterol Sulfate	48	11
Hydralazine Hcl	Hydralazine Hcl	47	12
Glipizide Er	Glipizide	45	16
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	13
Lovastatin	Lovastatin	44	11
Pregabalin	Pregabalin	44	suppressed
Sertraline Hcl	Sertraline Hcl	44	13
Glimepiride	Glimepiride	43	suppressed
Nystatin	Nystatin	43	21
Oxybutynin Chloride Er	Oxybutynin Chloride	43	16
Cephalexin	Cephalexin	42	31
Mounjaro	Tirzepatide	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Enalapril Maleate	Enalapril Maleate	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	11
Nifedipine Er	Nifedipine	36	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	35	12
Triamcinolone Acetonide	Triamcinolone Acetonide	35	19
Novolog Flexpen	Insulin Aspart	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	11
Amoxicillin	Amoxicillin	31	30
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Methocarbamol	Methocarbamol	31	13
Temazepam	Temazepam	31	suppressed
Spironolactone	Spironolactone	30	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	12
Rosuvastatin Calcium	Rosuvastatin Calcium	29	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	27	suppressed
Fluconazole	Fluconazole	27	17
Benazepril Hcl	Benazepril Hcl	26	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Baclofen	Baclofen	23	suppressed
Irbesartan	Irbesartan	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	14
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	15
Linzess	Linaclotide	20	suppressed
Clobetasol Propionate	Clobetasol Propionate	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Trazodone Hcl	Trazodone Hcl	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Diazepam	Diazepam	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Azithromycin	Azithromycin	16	12
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Bethanechol Chloride	Bethanechol Chloride	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Loperamide	Loperamide Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Fenofibrate	Fenofibrate	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Levetiracetam	Levetiracetam	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Ondansetron Odt	Ondansetron	14	13
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Estradiol	Estradiol	13	suppressed
Galantamine Hbr	Galantamine Hbr	13	suppressed
Memantine Hcl Er	Memantine Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Metronidazole	Metronidazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error